UK: A secondary analysis of the FINEARTS-HF randomized clinical trial evaluated the performance of the PREDICT-HFpEF model in ...

Officers, 10% owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the ...

Iowa property owners would save a combined $426 million over five years, statehouse Republicans say, under their proposal to overhaul the property tax system. Critics have worried about cuts leading ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

In the METEORIC-HF trial, omecamtiv was unable to show an improved performance in exercise capacity among patients with heart failure with reduced ejection fraction (HFrEF) compared to placebo.

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Trevi Therapeutics (TRVI) surges 40% premarket as Haduvio proves effective in reducing chronic coughing in trials.

Schumer Backs Spending Bill and Lines Up Enough Democrats to Pass It Many Democrats wanted to block Republicans’ measure in defiance of President Trump, but Senator Chuck Schumer said a shutdown ...

Paige Bueckers had 20 points to lead No. 3 UConn to a 71-40 win over St. John’s in the quarterfinals of the Big East women’s ...

Kirishima's hardening Quirk makes him an indestructible powerhouse with powerful punches. Re-Destro reveals his combat skills by transforming into a giant with immense strength. Mirio's permeation ...